Chest pain doesn't necessarily come from the heart. An estimated 200,000 Americans each year experience non-cardiac chest pain, which in addition to pain can involve painful swallowing, discomfort and anxiety. Non-cardiac chest pain can be frightening for patients and result in visits to the emergency room because the painful symptoms, while often originating in the esophagus, can mimic a heart attack. Current treatment—which includes pain modulators such as selective serotonin reuptake inhibitors (SSRI)—has a partial 40 to 50 percent response rate in alleviating symptoms.
New research authored by Temple University Hospital gastroenterologist Ron Schey, MD, FACG, suggests a novel approach to treating non-cardiac chest pain due to esophageal hypersensitivity. The treatment involves a drug called dronabinol, a cannabinoid receptor activator that has traditionally been used to treat nausea and vomiting in HIV patients and for cancer patients undergoing chemotherapy,
In a pilot study involving 13 patients with non-cardiac chest pain, Dr. Schey and his research team found that patients who were given 5 mg of dronabinol twice daily for four weeks fared better than patients who took a placebo, or dummy pill. Those getting dronabinol experienced improved pain tolerance and decreased frequency and intensity of chest pain. In addition, no significant adverse effects were reported.
"This novel study has promising findings in future treatment for these patients," said Dr. Schey, Associate Professor of Medicine at Temple University School of Medicine, who conducted the research while on staff at the University of Iowa Hospitals and Clinic, and analyzed the data at Temple along with Zubair Malik, MD, a first-year fellow in Temple's Division of Gastroenterology.
The pilot study, while encouraging, was very small and not designed to test dronabinol against current therapies for non-cardiac chest pain, so it is difficult to calculate how the drug performs in comparison to existing treatments, Dr. Schey said. He said dronabinol likely helps to diminish pain by activating cannabinoid receptors in the esophagus that decrease sensitivity.
The abstract was presented October 20 in Philadelphia at the Annual Scientific Meeting of the American College of Gastroenterology. The professional organization said it picked the Temple research to be among the "most newsworthy" studies presented at the conference because the findings have an impact on GI patient care.
Dr. Schey joined Temple in 2014; and his research interests include non-cardiac chest pain, GI motility disorders and esophageal disorders.
Dr. Schey said a larger scale study on the effects of dronabinol on non-cardiac chest pain will be initiated in the near future at Temple.
Explore further: Findings not supportive of women-specific chest pain symptoms in heart attack diagnosis
Medical Xpress on facebook
Related Stories
Chest pain duration can signal heart attack
Sep 11, 2013
Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.
What is the etiology of cardiac syndrome X?
Dec 01, 2008
Non-cardiac chest pain remains a widespread symptom especially in western countries with a significant economic burden. Patients with chest pain and abnormal electrocardiographic (ECG) but normal coronary angiogram (i.e. ...
Findings not supportive of women-specific chest pain symptoms in heart attack diagnosis
Nov 25, 2013
Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published ...
Chest pain prior to a heart attack can protect the heart
Feb 05, 2013
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers ...
Outcomes of patients dismissed from the hospital with non-cardiac chest pain
Apr 20, 2010
The growing number of Americans with cardiovascular disease has caused a heightened sensitivity in the evaluation of chest pain. In a study published in the April issue of Mayo Clinic Proceedings researchers reported that p ...
Recommended for you
Novel bi-directional cannula that prevents severe complications following cardiac surgery
3 hours ago
A novel bi-directional cannula that prevents severe complications following cardiac surgery has been developed by School of Clinical Sciences' Mr Randall Moshinsky.
New treatment for inherited cholesterol
4 hours ago
At the London Olympics in 2012, South African swimmer Cameron van den Burgh dedicated his world record-breaking win in the 100m breast stroke to one of his biggest rivals and closest friends, Alexander Dale ...
Three ways to prevent sudden heart death in fit, young athletes
5 hours ago
Fifteen year-old Marshall Hastings is living proof of the value of having life-saving cardiac defibrillators and trained personnel at sporting events.
Alternate approach to traditional CPR saves lives
10 hours ago
A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR). The study ...
Seeing doctor twice a year helps keep blood pressure under control
21 hours ago
People who visited their doctor at least twice a year were 3.2 times more likely to keep their blood pressure under control than those who saw their doctor once a year or less, according to new research in the American Heart ...
Heart rate may predict survival and brain function in comatose cardiac arrest survivors
Oct 20, 2014
Researchers may have developed a way to potentially assist prognostication in the first 24 hours after out-of-hospital cardiac arrest (OHCA) when patients are still in a coma. Their findings are revealed ...
User comments
© Medical Xpress 2011-2014, Science X network
Chest pain doesn't necessarily come from the heart. An estimated 200,000 Americans each year experience non-cardiac chest pain, which in addition to pain can involve painful swallowing, discomfort and anxiety. Non-cardiac chest pain can be frightening for patients and result in visits to the emergency room because the painful symptoms, while often originating in the esophagus, can mimic a heart attack. Current treatment—which includes pain modulators such as selective serotonin reuptake inhibitors (SSRI)—has a partial 40 to 50 percent response rate in alleviating symptoms.
New research authored by Temple University Hospital gastroenterologist Ron Schey, MD, FACG, suggests a novel approach to treating non-cardiac chest pain due to esophageal hypersensitivity. The treatment involves a drug called dronabinol, a cannabinoid receptor activator that has traditionally been used to treat nausea and vomiting in HIV patients and for cancer patients undergoing chemotherapy,
In a pilot study involving 13 patients with non-cardiac chest pain, Dr. Schey and his research team found that patients who were given 5 mg of dronabinol twice daily for four weeks fared better than patients who took a placebo, or dummy pill. Those getting dronabinol experienced improved pain tolerance and decreased frequency and intensity of chest pain. In addition, no significant adverse effects were reported.
"This novel study has promising findings in future treatment for these patients," said Dr. Schey, Associate Professor of Medicine at Temple University School of Medicine, who conducted the research while on staff at the University of Iowa Hospitals and Clinic, and analyzed the data at Temple along with Zubair Malik, MD, a first-year fellow in Temple's Division of Gastroenterology.
The pilot study, while encouraging, was very small and not designed to test dronabinol against current therapies for non-cardiac chest pain, so it is difficult to calculate how the drug performs in comparison to existing treatments, Dr. Schey said. He said dronabinol likely helps to diminish pain by activating cannabinoid receptors in the esophagus that decrease sensitivity.
The abstract was presented October 20 in Philadelphia at the Annual Scientific Meeting of the American College of Gastroenterology. The professional organization said it picked the Temple research to be among the "most newsworthy" studies presented at the conference because the findings have an impact on GI patient care.
Dr. Schey joined Temple in 2014; and his research interests include non-cardiac chest pain, GI motility disorders and esophageal disorders.
Dr. Schey said a larger scale study on the effects of dronabinol on non-cardiac chest pain will be initiated in the near future at Temple.
Explore further: Findings not supportive of women-specific chest pain symptoms in heart attack diagnosis
Medical Xpress on facebook
Related Stories
Chest pain duration can signal heart attack
Sep 11, 2013
Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.
What is the etiology of cardiac syndrome X?
Dec 01, 2008
Non-cardiac chest pain remains a widespread symptom especially in western countries with a significant economic burden. Patients with chest pain and abnormal electrocardiographic (ECG) but normal coronary angiogram (i.e. ...
Findings not supportive of women-specific chest pain symptoms in heart attack diagnosis
Nov 25, 2013
Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published ...
Chest pain prior to a heart attack can protect the heart
Feb 05, 2013
Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers ...
Outcomes of patients dismissed from the hospital with non-cardiac chest pain
Apr 20, 2010
The growing number of Americans with cardiovascular disease has caused a heightened sensitivity in the evaluation of chest pain. In a study published in the April issue of Mayo Clinic Proceedings researchers reported that p ...
Recommended for you
Novel bi-directional cannula that prevents severe complications following cardiac surgery
3 hours ago
A novel bi-directional cannula that prevents severe complications following cardiac surgery has been developed by School of Clinical Sciences' Mr Randall Moshinsky.
New treatment for inherited cholesterol
4 hours ago
At the London Olympics in 2012, South African swimmer Cameron van den Burgh dedicated his world record-breaking win in the 100m breast stroke to one of his biggest rivals and closest friends, Alexander Dale ...
Three ways to prevent sudden heart death in fit, young athletes
5 hours ago
Fifteen year-old Marshall Hastings is living proof of the value of having life-saving cardiac defibrillators and trained personnel at sporting events.
Alternate approach to traditional CPR saves lives
10 hours ago
A new study shows that survival and neurological outcomes for patients in cardiac arrest can be improved by adding extracorporeal membrane oxygenation (ECMO) when performing cardiopulmonary resuscitation (CPR). The study ...
Seeing doctor twice a year helps keep blood pressure under control
21 hours ago
People who visited their doctor at least twice a year were 3.2 times more likely to keep their blood pressure under control than those who saw their doctor once a year or less, according to new research in the American Heart ...
Heart rate may predict survival and brain function in comatose cardiac arrest survivors
Oct 20, 2014
Researchers may have developed a way to potentially assist prognostication in the first 24 hours after out-of-hospital cardiac arrest (OHCA) when patients are still in a coma. Their findings are revealed ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment